History, Mission and Scope

History

Headache Medicine has been published since 2010 and was previously issued under the title Migraneas & Cefaléias, which had been in circulation since 1994.

Previous editors include: Edgard Raffaelli Junior (1994–1995), José Geraldo Speciali (1996–2002), Carlos Alberto Bordini (1996–1997), Abouch Valenty Krymchantowsky (2002–2004), Pedro André Kowacs and Paulo H. Monzillo (2004–2007), Fernando Kowacs (2008–2013), Marcelo Moraes Valença (2014–present), Marcelo Moraes Valença and Raimundo Silva-Neto (2022–February 2026), and Marcelo Moraes Valença (March 2026–present).

In 2019, Editors-in-Chief Marcelo Moraes Valença and Mario Fernando Prieto Peres restructured the journal’s editorial board at both national and international levels through the appointment of new associate editors. Together with the Executive Editor, Juliana Ramos de Andrade, the journal also underwent a renewal of its editorial format. Following modern editorial trends, Headache Medicine adopted a continuous online publication model for accepted articles.

Mission

The mission of Headache Medicine is to publish high-quality, peer-reviewed research on headache, orofacial pain, and related disorders. The journal aims to contribute to the advancement of scientific knowledge in the field and to support continuing medical education through the dissemination of rigorous clinical and experimental studies.

Scope

The journal publishes manuscripts related to headache, orofacial pain, and associated disorders, including topics that may have implications for headache research and clinical practice. The scope encompasses clinical and experimental studies, qualitative and quantitative research, and investigations using animal models that contribute to understanding disease pathophysiology and pharmacological mechanisms.

In addition, the journal welcomes methodological and theoretical studies, explanatory models, and scientific images published in the online version. Headache Medicine seeks to disseminate innovations in the diagnosis and treatment of headache disorders and to foster the exchange of knowledge within the international scientific community.

Manuscripts may be submitted in Portuguese, Spanish, or English; however, accepted articles are translated and published exclusively in English. All submissions undergo an initial editorial screening followed by single-blind peer review.